BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 27089554)

  • 1. MRI-based IMRT planning for MR-linac: comparison between CT- and MRI-based plans for pancreatic and prostate cancers.
    Prior P; Chen X; Botros M; Paulson ES; Lawton C; Erickson B; Li XA
    Phys Med Biol; 2016 May; 61(10):3819-42. PubMed ID: 27089554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technical Note: Is bulk electron density assignment appropriate for MRI-only based treatment planning for lung cancer?
    Prior P; Chen X; Gore E; Johnstone C; Li XA
    Med Phys; 2017 Jul; 44(7):3437-3443. PubMed ID: 28391596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer.
    Da Silva Mendes V; Nierer L; Li M; Corradini S; Reiner M; Kamp F; Niyazi M; Kurz C; Landry G; Belka C
    Radiat Oncol; 2021 Jul; 16(1):133. PubMed ID: 34289868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI-based treatment planning for radiotherapy: dosimetric verification for prostate IMRT.
    Chen L; Price RA; Wang L; Li J; Qin L; McNeeley S; Ma CM; Freedman GM; Pollack A
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):636-47. PubMed ID: 15380601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sparing the penile bulb in the radical irradiation of clinically localised prostate carcinoma: A comparison between MRI and CT prostatic apex definition in 3DCRT, Linac-IMRT and Helical Tomotherapy.
    Perna L; Fiorino C; Cozzarini C; Broggi S; Cattaneo GM; De Cobelli F; Mangili P; Di Muzio N; Calandrino R
    Radiother Oncol; 2009 Oct; 93(1):57-63. PubMed ID: 19410316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of field number and beam angle on ERE for lung stereotactic body radiotherapy with 1.5T MR-Linac.
    Ding S; Liu H; Wang B; Li Y; Li R; Liu B; Xia Y; Huang X
    Cancer Radiother; 2021 Jun; 25(4):366-372. PubMed ID: 33622638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technical Note: Dose effects of 1.5 T transverse magnetic field on tissue interfaces in MRI-guided radiotherapy.
    Chen X; Prior P; Chen GP; Schultz CJ; Li XA
    Med Phys; 2016 Aug; 43(8):4797. PubMed ID: 27487897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Monte-Carlo study to assess the effect of 1.5 T magnetic fields on the overall robustness of pencil-beam scanning proton radiotherapy plans for prostate cancer.
    Kurz C; Landry G; Resch AF; Dedes G; Kamp F; Ganswindt U; Belka C; Raaymakers BW; Parodi K
    Phys Med Biol; 2017 Oct; 62(21):8470-8482. PubMed ID: 29047455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of margin reduction on radiation dose distribution of ultra-hypofractionated prostate radiotherapy utilizing a 1.5-T MR-Linac.
    Onal C; Efe E; Bozca R; Yavas C; Yavas G; Arslan G
    J Appl Clin Med Phys; 2024 Jan; 25(1):e14179. PubMed ID: 38013636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric evaluation of synthetic CT relative to bulk density assignment-based magnetic resonance-only approaches for prostate radiotherapy.
    Kim J; Garbarino K; Schultz L; Levin K; Movsas B; Siddiqui MS; Chetty IJ; Glide-Hurst C
    Radiat Oncol; 2015 Nov; 10():239. PubMed ID: 26597251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards abdominal MRI-based treatment planning using population-based Hounsfield units for bulk density assignment.
    Hsu SH; Zawisza I; O'Grady K; Peng Q; Tomé WA
    Phys Med Biol; 2018 Jul; 63(15):155003. PubMed ID: 29952320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IMRT boost dose planning on dominant intraprostatic lesions: gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI.
    van Lin EN; Fütterer JJ; Heijmink SW; van der Vight LP; Hoffmann AL; van Kollenburg P; Huisman HJ; Scheenen TW; Witjes JA; Leer JW; Barentsz JO; Visser AG
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):291-303. PubMed ID: 16618584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of treatment planning workflow and tumor coverage during daily adaptive magnetic resonance image guided radiation therapy (MR-IGRT) of pancreatic cancer.
    Olberg S; Green O; Cai B; Yang D; Rodriguez V; Zhang H; Kim JS; Parikh PJ; Mutic S; Park JC
    Radiat Oncol; 2018 Mar; 13(1):51. PubMed ID: 29573744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective study comparing MR-guided radiation therapy (MRgRT) setup strategies for prostate treatment: repositioning vs. replanning.
    Kim JI; Park JM; Choi CH; An HJ; Kim YJ; Kim JH
    Radiat Oncol; 2019 Aug; 14(1):139. PubMed ID: 31387593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity-modulated radiation therapy for pancreatic and prostate cancer using pulsed low-dose rate delivery techniques.
    Li J; Lang J; Wang P; Kang S; Lin MH; Chen X; Chen F; Guo M; Chen L; Ma CM
    Med Dosim; 2014; 39(4):330-6. PubMed ID: 25087084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of MRI-only treatment planning for proton therapy in brain and prostate cancers: Dose calculation accuracy in substitute CT images.
    Koivula L; Wee L; Korhonen J
    Med Phys; 2016 Aug; 43(8):4634. PubMed ID: 27487880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance only workflow and validation of dose calculations for radiotherapy of prostate cancer.
    Christiansen RL; Jensen HR; Brink C
    Acta Oncol; 2017 Jun; 56(6):787-791. PubMed ID: 28464739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a simplified optimizer for MR-guided adaptive RT in case of pancreatic cancer.
    Cusumano D; Boldrini L; Menna S; Teodoli S; Placidi E; Chiloiro G; Placidi L; Greco F; Stimato G; Cellini F; Valentini V; Azario L; De Spirito M
    J Appl Clin Med Phys; 2019 Sep; 20(9):20-30. PubMed ID: 31444952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the Hounsfield unit assignment and dose differences between CT-based standard and deep learning-based synthetic CT images for MRI-only radiation therapy of the head and neck.
    Singhrao K; Dugan CL; Calvin C; Pelayo L; Yom SS; Chan JW; Scholey JE; Singer L
    J Appl Clin Med Phys; 2024 Jan; 25(1):e14239. PubMed ID: 38128040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of the factors which affect the interpatient organ-at-risk dose sparing variation in IMRT plans.
    Yuan L; Ge Y; Lee WR; Yin FF; Kirkpatrick JP; Wu QJ
    Med Phys; 2012 Nov; 39(11):6868-78. PubMed ID: 23127079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.